Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
C09DB Angiotensin II receptor blockers (ARBs) and calcium channel blockers
C09DB01 Valsartan and amlodipine
D09745 Valsartan and amlodipine besilate <JP/US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Cardiovascular Combinations
Amlodipine Besylate/ Valsartan
D09745 Valsartan and amlodipine besilate
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
214 Antihypertensives
2149 Others
D09745 Valsartan and amlodipine besilate
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
D09745 Valsartan and amlodipine besilate
DG03231 Antihypertensive
D09745 Valsartan and amlodipine besilate
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D09745 Valsartan and amlodipine besilate
Drug classes [BR:br08332]
Cardiovascular agent
DG03231 Antihypertensive
D09745 Valsartan and amlodipine besilate
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09745
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09745